Stock Price
723.20
Daily Change
4.60 0.64%
Monthly
5.79%
Yearly
12.79%
Q1 Forecast
686.63

argenx SE reported $349.97M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AstraZeneca USD -1.5B 5.01B Sep/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Qiagen NV USD 137.29M 1.32M Sep/2025
UCB EUR 1B 678M Dec/2024